GO:0005975 | carbohydrate metabolic process | 10.14% (21/207) | 3.39 | 0.0 | 0.0 |
GO:0046496 | nicotinamide nucleotide metabolic process | 4.83% (10/207) | 4.13 | 0.0 | 0.0 |
GO:0019362 | pyridine nucleotide metabolic process | 4.83% (10/207) | 4.13 | 0.0 | 0.0 |
GO:0046434 | organophosphate catabolic process | 4.83% (10/207) | 4.07 | 0.0 | 0.0 |
GO:0072524 | pyridine-containing compound metabolic process | 4.83% (10/207) | 4.07 | 0.0 | 0.0 |
GO:0006733 | oxidoreduction coenzyme metabolic process | 4.83% (10/207) | 4.01 | 0.0 | 0.0 |
GO:0019693 | ribose phosphate metabolic process | 5.8% (12/207) | 3.56 | 0.0 | 0.0 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 3.86% (8/207) | 4.43 | 0.0 | 0.0 |
GO:0006757 | ATP generation from ADP | 3.86% (8/207) | 4.43 | 0.0 | 0.0 |
GO:0046939 | nucleotide phosphorylation | 3.86% (8/207) | 4.43 | 0.0 | 0.0 |
GO:0009132 | nucleoside diphosphate metabolic process | 3.86% (8/207) | 4.43 | 0.0 | 0.0 |
GO:0042866 | pyruvate biosynthetic process | 3.86% (8/207) | 4.43 | 0.0 | 0.0 |
GO:0046031 | ADP metabolic process | 3.86% (8/207) | 4.43 | 0.0 | 0.0 |
GO:0006165 | nucleoside diphosphate phosphorylation | 3.86% (8/207) | 4.43 | 0.0 | 0.0 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 3.86% (8/207) | 4.43 | 0.0 | 0.0 |
GO:0006096 | glycolytic process | 3.86% (8/207) | 4.43 | 0.0 | 0.0 |
GO:0009135 | purine nucleoside diphosphate metabolic process | 3.86% (8/207) | 4.43 | 0.0 | 0.0 |
GO:0046034 | ATP metabolic process | 4.83% (10/207) | 3.96 | 0.0 | 0.0 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 6.76% (14/207) | 3.05 | 0.0 | 0.0 |
GO:0009141 | nucleoside triphosphate metabolic process | 5.31% (11/207) | 3.89 | 0.0 | 0.0 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 4.83% (10/207) | 3.9 | 0.0 | 0.0 |
GO:0044270 | cellular nitrogen compound catabolic process | 4.83% (10/207) | 3.9 | 0.0 | 0.0 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 4.83% (10/207) | 3.9 | 0.0 | 0.0 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 4.83% (10/207) | 3.9 | 0.0 | 0.0 |
GO:0044281 | small molecule metabolic process | 11.11% (23/207) | 2.19 | 0.0 | 0.0 |
GO:0006753 | nucleoside phosphate metabolic process | 6.28% (13/207) | 3.18 | 0.0 | 0.0 |
GO:0009161 | ribonucleoside monophosphate metabolic process | 4.83% (10/207) | 3.75 | 0.0 | 0.0 |
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 4.83% (10/207) | 3.75 | 0.0 | 0.0 |
GO:0009126 | purine nucleoside monophosphate metabolic process | 4.83% (10/207) | 3.75 | 0.0 | 0.0 |
GO:0009123 | nucleoside monophosphate metabolic process | 4.83% (10/207) | 3.75 | 0.0 | 0.0 |
GO:1901292 | nucleoside phosphate catabolic process | 4.35% (9/207) | 4.11 | 0.0 | 0.0 |
GO:1901135 | carbohydrate derivative metabolic process | 6.76% (14/207) | 3.08 | 0.0 | 0.0 |
GO:0003824 | catalytic activity | 37.2% (77/207) | 0.96 | 0.0 | 0.0 |
GO:0006090 | pyruvate metabolic process | 3.86% (8/207) | 4.33 | 0.0 | 0.0 |
GO:0006796 | phosphate-containing compound metabolic process | 13.53% (28/207) | 1.86 | 0.0 | 0.0 |
GO:0006793 | phosphorus metabolic process | 13.53% (28/207) | 1.86 | 0.0 | 0.0 |
GO:0034655 | nucleobase-containing compound catabolic process | 4.35% (9/207) | 3.92 | 0.0 | 0.0 |
GO:0009166 | nucleotide catabolic process | 3.86% (8/207) | 4.17 | 0.0 | 0.0 |
GO:0034404 | nucleobase-containing small molecule biosynthetic process | 4.35% (9/207) | 3.86 | 0.0 | 0.0 |
GO:1901361 | organic cyclic compound catabolic process | 4.35% (9/207) | 3.8 | 0.0 | 0.0 |
GO:0046700 | heterocycle catabolic process | 4.35% (9/207) | 3.8 | 0.0 | 0.0 |
GO:0019439 | aromatic compound catabolic process | 4.35% (9/207) | 3.8 | 0.0 | 0.0 |
GO:0009117 | nucleotide metabolic process | 5.8% (12/207) | 3.14 | 0.0 | 0.0 |
GO:0019637 | organophosphate metabolic process | 7.25% (15/207) | 2.72 | 0.0 | 0.0 |
GO:0017144 | drug metabolic process | 5.31% (11/207) | 3.33 | 0.0 | 0.0 |
GO:0016052 | carbohydrate catabolic process | 3.86% (8/207) | 4.09 | 0.0 | 0.0 |
GO:0009259 | ribonucleotide metabolic process | 4.83% (10/207) | 3.45 | 0.0 | 0.0 |
GO:0009150 | purine ribonucleotide metabolic process | 4.83% (10/207) | 3.45 | 0.0 | 0.0 |
GO:0044283 | small molecule biosynthetic process | 6.76% (14/207) | 2.75 | 0.0 | 0.0 |
GO:0019359 | nicotinamide nucleotide biosynthetic process | 3.86% (8/207) | 3.94 | 0.0 | 0.0 |
GO:0019363 | pyridine nucleotide biosynthetic process | 3.86% (8/207) | 3.94 | 0.0 | 0.0 |
GO:0006163 | purine nucleotide metabolic process | 4.83% (10/207) | 3.37 | 0.0 | 0.0 |
GO:0006091 | generation of precursor metabolites and energy | 3.86% (8/207) | 3.88 | 0.0 | 0.0 |
GO:0072525 | pyridine-containing compound biosynthetic process | 3.86% (8/207) | 3.88 | 0.0 | 0.0 |
GO:0006732 | coenzyme metabolic process | 4.83% (10/207) | 3.33 | 0.0 | 0.0 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 3.86% (8/207) | 3.81 | 0.0 | 0.0 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 3.86% (8/207) | 3.81 | 0.0 | 0.0 |
GO:0006754 | ATP biosynthetic process | 3.86% (8/207) | 3.81 | 0.0 | 0.0 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 3.86% (8/207) | 3.81 | 0.0 | 0.0 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 3.86% (8/207) | 3.81 | 0.0 | 0.0 |
GO:0051186 | cofactor metabolic process | 5.8% (12/207) | 2.92 | 0.0 | 0.0 |
GO:0072521 | purine-containing compound metabolic process | 4.83% (10/207) | 3.26 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 51.69% (107/207) | 0.61 | 0.0 | 0.0 |
GO:0016053 | organic acid biosynthetic process | 5.31% (11/207) | 3.01 | 0.0 | 1e-06 |
GO:0046394 | carboxylic acid biosynthetic process | 5.31% (11/207) | 3.01 | 0.0 | 1e-06 |
GO:0072330 | monocarboxylic acid biosynthetic process | 3.86% (8/207) | 3.69 | 0.0 | 1e-06 |
GO:0008152 | metabolic process | 32.37% (67/207) | 0.87 | 0.0 | 1e-06 |
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 3.86% (8/207) | 3.58 | 0.0 | 1e-06 |
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 3.86% (8/207) | 3.58 | 0.0 | 1e-06 |
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 3.86% (8/207) | 3.58 | 0.0 | 1e-06 |
GO:0009124 | nucleoside monophosphate biosynthetic process | 3.86% (8/207) | 3.58 | 0.0 | 1e-06 |
GO:0016310 | phosphorylation | 10.14% (21/207) | 1.88 | 0.0 | 1e-06 |
GO:0009152 | purine ribonucleotide biosynthetic process | 3.86% (8/207) | 3.48 | 0.0 | 2e-06 |
GO:0046390 | ribose phosphate biosynthetic process | 3.86% (8/207) | 3.48 | 0.0 | 2e-06 |
GO:0009260 | ribonucleotide biosynthetic process | 3.86% (8/207) | 3.48 | 0.0 | 2e-06 |
GO:0051156 | glucose 6-phosphate metabolic process | 1.93% (4/207) | 5.33 | 0.0 | 2e-06 |
GO:0044248 | cellular catabolic process | 4.83% (10/207) | 2.96 | 0.0 | 3e-06 |
GO:0009056 | catabolic process | 5.31% (11/207) | 2.75 | 1e-06 | 3e-06 |
GO:1901575 | organic substance catabolic process | 5.31% (11/207) | 2.75 | 1e-06 | 3e-06 |
GO:0006164 | purine nucleotide biosynthetic process | 3.86% (8/207) | 3.38 | 1e-06 | 3e-06 |
GO:0032787 | monocarboxylic acid metabolic process | 3.86% (8/207) | 3.38 | 1e-06 | 3e-06 |
GO:0008150 | biological_process | 38.65% (80/207) | 0.69 | 1e-06 | 7e-06 |
GO:0072522 | purine-containing compound biosynthetic process | 3.86% (8/207) | 3.25 | 1e-06 | 7e-06 |
GO:0016616 | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.86% (8/207) | 3.21 | 2e-06 | 9e-06 |
GO:0009108 | coenzyme biosynthetic process | 3.86% (8/207) | 3.17 | 2e-06 | 1.1e-05 |
GO:0051188 | cofactor biosynthetic process | 4.35% (9/207) | 2.92 | 2e-06 | 1.1e-05 |
GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors | 3.86% (8/207) | 3.09 | 3e-06 | 1.6e-05 |
GO:0055114 | oxidation-reduction process | 10.14% (21/207) | 1.65 | 3e-06 | 1.6e-05 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 9.18% (19/207) | 1.72 | 5e-06 | 2.3e-05 |
GO:1901293 | nucleoside phosphate biosynthetic process | 3.86% (8/207) | 2.98 | 6e-06 | 2.8e-05 |
GO:0009165 | nucleotide biosynthetic process | 3.86% (8/207) | 2.98 | 6e-06 | 2.8e-05 |
GO:1901137 | carbohydrate derivative biosynthetic process | 3.86% (8/207) | 2.94 | 7e-06 | 3.3e-05 |
GO:0019752 | carboxylic acid metabolic process | 6.28% (13/207) | 2.14 | 7e-06 | 3.4e-05 |
GO:0006082 | organic acid metabolic process | 6.28% (13/207) | 2.09 | 1e-05 | 4.7e-05 |
GO:0043436 | oxoacid metabolic process | 6.28% (13/207) | 2.09 | 1e-05 | 4.7e-05 |
GO:0016491 | oxidoreductase activity | 10.14% (21/207) | 1.54 | 1e-05 | 4.8e-05 |
GO:0019200 | carbohydrate kinase activity | 1.93% (4/207) | 4.53 | 1.2e-05 | 5.5e-05 |
GO:0090407 | organophosphate biosynthetic process | 4.35% (9/207) | 2.55 | 1.9e-05 | 8.6e-05 |
GO:0071704 | organic substance metabolic process | 24.64% (51/207) | 0.82 | 2.5e-05 | 0.000109 |
GO:0044238 | primary metabolic process | 23.67% (49/207) | 0.84 | 2.5e-05 | 0.000112 |
GO:0016301 | kinase activity | 8.7% (18/207) | 1.59 | 2.8e-05 | 0.000121 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 10.14% (21/207) | 1.44 | 3e-05 | 0.000129 |
GO:0098655 | cation transmembrane transport | 2.9% (6/207) | 3.22 | 3.3e-05 | 0.000137 |
GO:0098662 | inorganic cation transmembrane transport | 2.9% (6/207) | 3.22 | 3.3e-05 | 0.000137 |
GO:0098660 | inorganic ion transmembrane transport | 2.9% (6/207) | 3.22 | 3.3e-05 | 0.000137 |
GO:0006812 | cation transport | 4.35% (9/207) | 2.44 | 3.6e-05 | 0.000151 |
GO:0034220 | ion transmembrane transport | 2.9% (6/207) | 3.01 | 7.8e-05 | 0.000319 |
GO:0000166 | nucleotide binding | 15.46% (32/207) | 0.96 | 0.000178 | 0.000719 |
GO:1901265 | nucleoside phosphate binding | 15.46% (32/207) | 0.96 | 0.000178 | 0.000719 |
GO:0018130 | heterocycle biosynthetic process | 5.8% (12/207) | 1.76 | 0.000214 | 0.000855 |
GO:0036094 | small molecule binding | 15.94% (33/207) | 0.92 | 0.000248 | 0.000981 |
GO:1902600 | proton transmembrane transport | 2.42% (5/207) | 3.07 | 0.000257 | 0.001009 |
GO:1901564 | organonitrogen compound metabolic process | 15.46% (32/207) | 0.93 | 0.000261 | 0.001015 |
GO:1901362 | organic cyclic compound biosynthetic process | 5.8% (12/207) | 1.65 | 0.000425 | 0.001637 |
GO:0006006 | glucose metabolic process | 1.45% (3/207) | 4.11 | 0.000487 | 0.001861 |
GO:0019438 | aromatic compound biosynthetic process | 5.31% (11/207) | 1.7 | 0.000572 | 0.002165 |
GO:0006098 | pentose-phosphate shunt | 0.97% (2/207) | 5.33 | 0.000611 | 0.002198 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 0.97% (2/207) | 5.33 | 0.000611 | 0.002198 |
GO:0005536 | glucose binding | 0.97% (2/207) | 5.33 | 0.000611 | 0.002198 |
GO:0004396 | hexokinase activity | 0.97% (2/207) | 5.33 | 0.000611 | 0.002198 |
GO:0004340 | glucokinase activity | 0.97% (2/207) | 5.33 | 0.000611 | 0.002198 |
GO:0004347 | glucose-6-phosphate isomerase activity | 0.97% (2/207) | 5.33 | 0.000611 | 0.002198 |
GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.45% (3/207) | 3.92 | 0.000766 | 0.002733 |
GO:0016740 | transferase activity | 13.04% (27/207) | 0.93 | 0.000885 | 0.003132 |
GO:0015672 | monovalent inorganic cation transport | 2.42% (5/207) | 2.7 | 0.000894 | 0.003139 |
GO:0043167 | ion binding | 17.87% (37/207) | 0.76 | 0.000918 | 0.0032 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4.35% (9/207) | 1.82 | 0.00099 | 0.003424 |
GO:0097159 | organic cyclic compound binding | 20.77% (43/207) | 0.68 | 0.001012 | 0.003442 |
GO:1901363 | heterocyclic compound binding | 20.77% (43/207) | 0.68 | 0.001012 | 0.003442 |
GO:0005996 | monosaccharide metabolic process | 1.45% (3/207) | 3.75 | 0.001128 | 0.00364 |
GO:0090662 | ATP hydrolysis coupled transmembrane transport | 1.45% (3/207) | 3.75 | 0.001128 | 0.00364 |
GO:0015991 | ATP hydrolysis coupled proton transport | 1.45% (3/207) | 3.75 | 0.001128 | 0.00364 |
GO:0099131 | ATP hydrolysis coupled ion transmembrane transport | 1.45% (3/207) | 3.75 | 0.001128 | 0.00364 |
GO:0019318 | hexose metabolic process | 1.45% (3/207) | 3.75 | 0.001128 | 0.00364 |
GO:0099132 | ATP hydrolysis coupled cation transmembrane transport | 1.45% (3/207) | 3.75 | 0.001128 | 0.00364 |
GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient | 1.45% (3/207) | 3.75 | 0.001128 | 0.00364 |
GO:1901566 | organonitrogen compound biosynthetic process | 6.28% (13/207) | 1.39 | 0.00137 | 0.004391 |
GO:0050662 | coenzyme binding | 4.35% (9/207) | 1.74 | 0.001481 | 0.004711 |
GO:0050661 | NADP binding | 1.45% (3/207) | 3.6 | 0.001582 | 0.004959 |
GO:0006811 | ion transport | 4.35% (9/207) | 1.72 | 0.001579 | 0.004987 |
GO:0008324 | cation transmembrane transporter activity | 2.9% (6/207) | 2.22 | 0.001694 | 0.005273 |
GO:0004743 | pyruvate kinase activity | 0.97% (2/207) | 4.75 | 0.001803 | 0.005458 |
GO:0003872 | 6-phosphofructokinase activity | 0.97% (2/207) | 4.75 | 0.001803 | 0.005458 |
GO:0030955 | potassium ion binding | 0.97% (2/207) | 4.75 | 0.001803 | 0.005458 |
GO:0031420 | alkali metal ion binding | 0.97% (2/207) | 4.75 | 0.001803 | 0.005458 |
GO:0044237 | cellular metabolic process | 19.32% (40/207) | 0.66 | 0.001908 | 0.005737 |
GO:0046983 | protein dimerization activity | 1.45% (3/207) | 3.46 | 0.002135 | 0.006376 |
GO:0051287 | NAD binding | 1.93% (4/207) | 2.81 | 0.002239 | 0.00664 |
GO:0022890 | inorganic cation transmembrane transporter activity | 2.42% (5/207) | 2.41 | 0.002295 | 0.006761 |
GO:0030246 | carbohydrate binding | 1.93% (4/207) | 2.75 | 0.002635 | 0.007712 |
GO:0046872 | metal ion binding | 6.28% (13/207) | 1.25 | 0.003184 | 0.009258 |
GO:0005524 | ATP binding | 11.11% (23/207) | 0.88 | 0.003322 | 0.009595 |
GO:0043169 | cation binding | 6.28% (13/207) | 1.23 | 0.003577 | 0.009938 |
GO:0006094 | gluconeogenesis | 0.97% (2/207) | 4.33 | 0.003547 | 0.009981 |
GO:0019319 | hexose biosynthetic process | 0.97% (2/207) | 4.33 | 0.003547 | 0.009981 |
GO:0046364 | monosaccharide biosynthetic process | 0.97% (2/207) | 4.33 | 0.003547 | 0.009981 |
GO:0048029 | monosaccharide binding | 0.97% (2/207) | 4.33 | 0.003547 | 0.009981 |
GO:0032559 | adenyl ribonucleotide binding | 11.11% (23/207) | 0.87 | 0.003576 | 0.009998 |
GO:0030554 | adenyl nucleotide binding | 11.11% (23/207) | 0.86 | 0.003754 | 0.010364 |
GO:0005488 | binding | 27.54% (57/207) | 0.48 | 0.003822 | 0.010488 |
GO:0000287 | magnesium ion binding | 1.45% (3/207) | 3.11 | 0.004459 | 0.012157 |
GO:0006468 | protein phosphorylation | 5.8% (12/207) | 1.25 | 0.004529 | 0.012274 |
GO:0004672 | protein kinase activity | 5.8% (12/207) | 1.25 | 0.00471 | 0.012685 |
GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 0.97% (2/207) | 4.01 | 0.005815 | 0.015378 |
GO:0019682 | glyceraldehyde-3-phosphate metabolic process | 0.97% (2/207) | 4.01 | 0.005815 | 0.015378 |
GO:0008443 | phosphofructokinase activity | 0.97% (2/207) | 4.01 | 0.005815 | 0.015378 |
GO:0035639 | purine ribonucleoside triphosphate binding | 12.08% (25/207) | 0.76 | 0.006177 | 0.016238 |
GO:0032555 | purine ribonucleotide binding | 12.08% (25/207) | 0.76 | 0.006577 | 0.017187 |
GO:0017076 | purine nucleotide binding | 12.08% (25/207) | 0.75 | 0.006856 | 0.017808 |
GO:0032553 | ribonucleotide binding | 12.08% (25/207) | 0.74 | 0.007442 | 0.019218 |
GO:0097367 | carbohydrate derivative binding | 12.08% (25/207) | 0.74 | 0.00775 | 0.019897 |
GO:0008144 | drug binding | 11.11% (23/207) | 0.77 | 0.007946 | 0.020163 |
GO:0009987 | cellular process | 20.29% (42/207) | 0.53 | 0.007932 | 0.020244 |
GO:0005509 | calcium ion binding | 2.42% (5/207) | 1.98 | 0.008287 | 0.020909 |
GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain | 0.97% (2/207) | 3.75 | 0.008581 | 0.021403 |
GO:0006081 | cellular aldehyde metabolic process | 0.97% (2/207) | 3.75 | 0.008581 | 0.021403 |
GO:1901576 | organic substance biosynthetic process | 7.73% (16/207) | 0.93 | 0.010211 | 0.025325 |
GO:0006807 | nitrogen compound metabolic process | 17.39% (36/207) | 0.56 | 0.010601 | 0.026144 |
GO:0006739 | NADP metabolic process | 0.97% (2/207) | 3.53 | 0.011818 | 0.028983 |
GO:0048037 | cofactor binding | 4.83% (10/207) | 1.17 | 0.01391 | 0.033925 |
GO:0015075 | ion transmembrane transporter activity | 2.9% (6/207) | 1.6 | 0.014138 | 0.034291 |
GO:0044249 | cellular biosynthetic process | 7.25% (15/207) | 0.9 | 0.014574 | 0.034962 |
GO:0006725 | cellular aromatic compound metabolic process | 9.18% (19/207) | 0.78 | 0.01454 | 0.035071 |
GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses | 0.97% (2/207) | 3.33 | 0.015502 | 0.036985 |
GO:0043168 | anion binding | 12.56% (26/207) | 0.64 | 0.015663 | 0.037168 |
GO:0046483 | heterocycle metabolic process | 9.18% (19/207) | 0.77 | 0.015844 | 0.037396 |
GO:0016798 | hydrolase activity, acting on glycosyl bonds | 1.45% (3/207) | 2.46 | 0.016312 | 0.038294 |
GO:0055085 | transmembrane transport | 4.35% (9/207) | 1.2 | 0.016552 | 0.038651 |
GO:0022857 | transmembrane transporter activity | 3.86% (8/207) | 1.28 | 0.017338 | 0.040272 |
GO:0015077 | monovalent inorganic cation transmembrane transporter activity | 1.45% (3/207) | 2.4 | 0.018423 | 0.042343 |
GO:0015078 | proton transmembrane transporter activity | 1.45% (3/207) | 2.4 | 0.018423 | 0.042343 |
GO:1901360 | organic cyclic compound metabolic process | 9.18% (19/207) | 0.73 | 0.020316 | 0.046452 |
GO:0030001 | metal ion transport | 1.45% (3/207) | 2.33 | 0.020678 | 0.047035 |
GO:0016852 | sirohydrochlorin cobaltochelatase activity | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0033202 | DNA helicase complex | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:1905862 | ferroxidase complex | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0004590 | orotidine-5'-phosphate decarboxylase activity | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0070603 | SWI/SNF superfamily-type complex | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0043605 | cellular amide catabolic process | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0031011 | Ino80 complex | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0043419 | urea catabolic process | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0009236 | cobalamin biosynthetic process | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0000702 | oxidized base lesion DNA N-glycosylase activity | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0019627 | urea metabolic process | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0019856 | pyrimidine nucleobase biosynthetic process | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0097346 | INO80-type complex | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0033573 | high-affinity iron permease complex | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0004645 | phosphorylase activity | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0031226 | intrinsic component of plasma membrane | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0006826 | iron ion transport | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0008184 | glycogen phosphorylase activity | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0005887 | integral component of plasma membrane | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0005381 | iron ion transmembrane transporter activity | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0004556 | alpha-amylase activity | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0006206 | pyrimidine nucleobase metabolic process | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0004635 | phosphoribosyl-AMP cyclohydrolase activity | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:1904949 | ATPase complex | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |
GO:0034755 | iron ion transmembrane transport | 0.48% (1/207) | 5.33 | 0.024776 | 0.048773 |